In addition to his practice, Dr. Minas participates in clinical studies and has published his findings in professional journals. He participated in a recent study regarding the long-term durability of Carticel (autologuous cultured chondrocytes), according to a company news release. The data was presented at a meeting of the American Academy of Orthopaedic Surgeons, where Dr. Minas compared the results of ACI following a marrow stimulation technique versus no significant treatment. The research showed that patients who underwent previous marrow stimulation were three times as likely to experience a failed ACI procedure as those who had no previous treatment.
“The data show that in this patient population marrow stimulation technique like microfracture are not benign and can compromise a patient’s ability to benefit from a subsequent treatment with ACI, effectively limiting their future treatment options,” said Dr. Minas in the release. “Orthopedic surgeons should reconsider using marrow stimulation technique as first-line treatment for patients with larger chondral lesions. These techniques should be reserved for patients with smaller defects, in younger patients, where a good result is more predictable.”
During his career, Dr. Minas has sat on the board of the International Cartilage Repair Society and the Cartilage Research Foundation. He designed an interpositional device and patellofemoral joint prosthesis to help osteoarthritic patients avoid a total knee replacement. He is also an associate professor of orthopedics at Harvard Medical School in Boston.
Dr. Minas earned his medical degree from University of Toronto Faculty of Medicine in Ontario and completed joint reconstruction and total joint arthroplasty fellowships in at the Sunnybrook Medical Center in Toronto and Brigham and Women’s Hospital.
Learn more about Dr. Tom Minas.
Read other coverage on orthopedic and spine industry leaders:
– Orthopedic and Spine Industry Leader to Know: Dr. James F. Mooney III, of the Medical University of South Carolina
– Orthopedic and Spine Industry Leader to Know: Dr. Tarek O. Souryall of Texas Sports Medicine
